ThymoFox
PrivateCompany Overview
ThymoFox is a biotechnology company developing targeted, orally available medicines for thymus regeneration to restore immune function in aging and immunocompromised patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
thymic regenerationsmall-molecule drugsimmune rejuvenationbiotechlongevity therapeuticsdrug discoveryT-cell productionthymic involutionimmune reconstitutionanti-aging medicinebiopharmaceuticalpreclinical pipelinebiohacking
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThymoFox Comparables
Compare ThymoFox with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TECregen | 82% | |
| Intervene Immune | 78% | |
| Tolerance Bio, Inc. | 77% | |
ThymoFox Funding Rounds
Historical fundraising activity
ThymoFox Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ThymoFox's valuation, stock price, and market status.
See something wrong or outdated?